i2o's ionic liquid platform overcomes the four key challenges to bioavailability:
Ionic Liquids and Deep Eutectic Solvents for Enhanced Delivery of Antibodies in the Gastrointestinal Tract Advanced Functional Materials | June 2020
Materials for oral delivery of proteins and peptides Nature Reviews Materials | December 2019
Ionic liquids for oral insulin delivery PNAS | June 2018
Ionic liquids for addressing unmet needs in healthcare Bioengineering & Translational Medicine | December 2017